Search

Displaying results 211 - 220 of 9220 in total
  1. Drug

    Carfilzomib

    go.drugbank.com/drugs/DB08889
    ApprovedInvestigational

    FDA approved carfilzomib in July 2012 for the treatment of adults with relapsed or refractory multiple myeloma as monotherapy or combination therapy.[L39392]

    Products: KYPROLIS POWDER FOR SOLUTION FOR INFUSION 60MG/VIAL, KYPROLIS POWDER FOR SOLUTION FOR INFUSION 30 MG/VIAL
  2. Drug

    Coagulation Factor IX (Recombinant)

    go.drugbank.com/drugs/DB00100
    Approved

    It has a primary amino acid sequence that is identical to the Ala148 allelic form of human factor IX, and has structural and functional characteristics similar to those of endogenous factor IX. … medium that is then processed and purified for use as a pharmaceutical agent.

    Products: BENEFIX 1000 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU, BeneFIX Powder and Solvent for Solution for Injection 250iu/vial
  3. Drug

    Atriplex canescens pollen

    go.drugbank.com/drugs/DB10767
    Approved

    Atriplex canescens pollen is the pollen of the Atriplex canescens plant. Atriplex canescens pollen is mainly used in allergenic testing.

    Mixtures: Scale Atriplex Mix, Scale Atriplex MixSynonyms: wing scale pollen extract
  4. Drug

    Podophyllin

    go.drugbank.com/drugs/DB09094
    Approved

    Podophyllin is a resin extracted from the roots of Podophyllum peltatum (American mandrake) and Podophyllum emodi, which contains numerous compounds, amongst which is podophyllin (as well as the drug podophyllotoxin). Podophyllin is the ...

    Mixtures: PODOPHYLLIN PAINT, CO.Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Trastuzumab emtansine

    go.drugbank.com/drugs/DB05773
    ApprovedInvestigational

    Trastuzumab emtansine is marketed under the brand name Kadcyla and is indicated for use in HER2-positive, metastatic breast cancer patients who have already used taxane and/or trastuzumab for metastatic … T-DM1 combines two strategies-- anti-HER2 activity and targeted intracellular delivery of the potent anti-microtubule agent, DM1 (a maytansine derivative)--to produce cell cycle arrest and apoptosis.

    Synonyms: T-DM1Products: KADCYLA 100 MG IV INFUZYONLUK COZELTI KONSANTRESI ICIN TOZ, KADCYLA 160 MG IV INFUZYONLUK COZELTI KONSANTRESI ICIN TOZ
  6. Drug

    Trastuzumab

    go.drugbank.com/drugs/DB00072
    ApprovedInvestigational

    In December 2017, FDA approved OGIVRI (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction … It displays biosimilar properties as Herceptin according to clinical data.

    Products: HERCEPTIN 150 MG İNFÜZYONLUK ÇÖZELTİ İÇİN KONSANTRE TOZ, KANJİNTİ 150 MG İNFÜZYONLUK ÇÖZELTİ HAZIRLAMADA KULLANILACAK KONSANTRE İÇİN TOZ, 1 ADET
  7. Drug

    Calcipotriol

    go.drugbank.com/drugs/DB02300
    ApprovedInvestigational

    Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.

    Mixtures: Calcidermetha 50 Mikrogramm/g + 0,5 mg/g Salbe, Calcipotriol/Betamethason Dermapharm 50 Mikrogramm/g + 0,5 mg/g SalbeCategories: Antipsoriatics for Topical Use
  8. Drug

    Ceftazidime

    go.drugbank.com/drugs/DB00438
    ApprovedInvestigational

    [L32935] Ceftazidime was approved by the FDA on July 19, 1985, and is currently available either alone or in combination with the non-β-lactam β-lactamase inhibitor [avibactam] to treat a variety of

    Mixtures: CEFAZIME FOR INJECTION 1 g/vial, ZAVİCEFTA 2 G/0.5 G İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 10 ADETCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  9. Drug

    Cefixime

    go.drugbank.com/drugs/DB00671
    ApprovedInvestigational

    [A263026] However, cefixime is not recommended as a first-line of treatment for uncomplicated urogenital, anorectal, or pharyngeal gonorrhea because cefixime does not provide the same bactericidal effect … [L49293] The beta-lactam ring of cefixime inhibits bacterial cell wall synthesis by binding to the penicillin-binding proteins which will then result in lysis.

    Mixtures: SEFACUR 100 MG/62.5 MG ORAL SÜSPANSİYON HAZIRLAMAK İÇİN TOZ İÇEREN SAŞE, 20 ADET, SEFACUR 200 MG/62.5 MG ORAL SÜSPANSİYON HAZIRLAMAK İÇİN TOZ İÇEREN SAŞE, 20 ADETCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  10. Drug

    Betiatide

    go.drugbank.com/drugs/DB14082
    Approved

    Products: Kit for the Preparation of Technetium Tc99m Mertiatide, TECHNETIUM Tc 99m MERTIATIDE